Search Results 1101-1110 of 16349 for substance P

  1. Trastuzumab-dttb (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-dttb prevents the growth of some tumors that produce extra amounts of a certain substance known as the HER2 protein. It should only be used in ...

  2. Psychiatry and Psychology - Doctors - Mayo Clinic

    Find a doctor whose last name begins with the letter P P; There are no doctors whose last name begins with the letter Q Q; Find a doctor whose last name ...

  3. Publications - Sanjeev Nanda, M.D. - Mayo Clinic

    Carey P, Mohabbat AB, Wight E, Nanda S, Bonnes S, Blomberg D, Croghan IT, Schroeder D, Nordhues H. Lactation accommodations at continuing medical education ...

  4. Diseases and Conditions that Start with D - Mayo Clinic

    P · R · S · T · U · V ... Drug addiction (substance use disorder) · Drug allergy. Dry age-related macular ...

  5. Medical Research & Education - Mayo Clinic News Network

    Changes in vaping, other substance use, another side effect of COVID-19 featured. COVID-19. Changes in vaping, other substance use, another side effect of COVID ...

  6. Drugs and Supplements that Start with V - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “V” to learn about drug side effects, proper use and ...

  7. Extracorporeal membrane oxygenation (ECMO) - Doctors & Departments - Mayo Clinic

    Bertini P, et al. ECMO in COVID-19 patients: A systematic review and meta-analysis. Journal of Cardiothoracic and Vascular Anesthesia. 2022; doi:10.1053/j ...

  8. Publications - Scott Wright, M.D. - Mayo Clinic

    Epub 2024 Nov 06. View PubMed; Wright RS, Raal FJ, Koenig W, Landmesser U, Leiter LA, Vikarunnessa S, Lesogor A, Maheux P, Talloczy Z, Zang X, Schwartz GG, Ray ...

  9. Hematology - Clinical trials

    ... P. prophylactic PLND Q. no prophylactic PLND. Long-Term Follow-Up Of Patients Who Have Participated In Children's Oncology Group Studies. Rochester, Minn ...

  10. A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) - Mayo Clinic

    Taking medications known to induce CYP3A4 (CYP = Cytochrome P). Having an ... Subjects with a history of substance abuse (within the last 6 months).